Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience

Elizabeth M.J. Lee, Karen Xu, Emma Mosbrook, Amanda Links, Jessica Guzman, David R. Adams, Elise Flynn, Elise Valkanas, Camillo Toro, Cynthia J. Tifft, Cornelius F. Boerkoel, William A. Gahl, Murat Sincan

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose:Using single-nucleotide polymorphism (SNP) chip and exome sequence data from individuals participating in the National Institutes of Health (NIH) Undiagnosed Diseases Program (UDP), we evaluated the number and therapeutic informativeness of incidental pharmacogenetic variants.Methods:Pharmacogenomics Knowledgebase (PharmGKB) annotated sequence variants were identified in 1,101 individuals. Medication records of participants were used to identify individuals prescribed medications with a genetic variant that might alter efficacy.Results:A total of 395 sequence variants, including 19 PharmGKB 1A and 1B variants, were identified in SNP chip sequence data, and 388 variants, including 21 PharmGKB 1A and 1B variants, were identified in the exome sequence data. Nine participants had incidental pharmacogenetic variants associated with altered efficacy of a prescribed medication.Conclusions:Despite the small size of the NIH UDP patient cohort, we identified pharmacogenetic incidental findings potentially useful for guiding therapy. Consequently, groups conducting clinical genomic studies might consider reporting of pharmacogenetic incidental findings.

Original languageEnglish (US)
Pages (from-to)1303-1307
Number of pages5
JournalGenetics in Medicine
Volume18
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Incidental Findings
Pharmacogenetics
National Institutes of Health (U.S.)
Knowledge Bases
Exome
Single Nucleotide Polymorphism
Therapeutics

Keywords

  • NIH undiagnosed diseases program
  • next generation sequencing
  • pharmacogenomics
  • precision medicine
  • secondary findings

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Pharmacogenomic incidental findings in 308 families : The NIH Undiagnosed Diseases Program experience. / Lee, Elizabeth M.J.; Xu, Karen; Mosbrook, Emma; Links, Amanda; Guzman, Jessica; Adams, David R.; Flynn, Elise; Valkanas, Elise; Toro, Camillo; Tifft, Cynthia J.; Boerkoel, Cornelius F.; Gahl, William A.; Sincan, Murat.

In: Genetics in Medicine, Vol. 18, No. 12, 01.12.2016, p. 1303-1307.

Research output: Contribution to journalArticle

Lee, EMJ, Xu, K, Mosbrook, E, Links, A, Guzman, J, Adams, DR, Flynn, E, Valkanas, E, Toro, C, Tifft, CJ, Boerkoel, CF, Gahl, WA & Sincan, M 2016, 'Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience', Genetics in Medicine, vol. 18, no. 12, pp. 1303-1307. https://doi.org/10.1038/gim.2016.47
Lee, Elizabeth M.J. ; Xu, Karen ; Mosbrook, Emma ; Links, Amanda ; Guzman, Jessica ; Adams, David R. ; Flynn, Elise ; Valkanas, Elise ; Toro, Camillo ; Tifft, Cynthia J. ; Boerkoel, Cornelius F. ; Gahl, William A. ; Sincan, Murat. / Pharmacogenomic incidental findings in 308 families : The NIH Undiagnosed Diseases Program experience. In: Genetics in Medicine. 2016 ; Vol. 18, No. 12. pp. 1303-1307.
@article{03c1f6f3540b4fcd927f5c833c79d089,
title = "Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience",
abstract = "Purpose:Using single-nucleotide polymorphism (SNP) chip and exome sequence data from individuals participating in the National Institutes of Health (NIH) Undiagnosed Diseases Program (UDP), we evaluated the number and therapeutic informativeness of incidental pharmacogenetic variants.Methods:Pharmacogenomics Knowledgebase (PharmGKB) annotated sequence variants were identified in 1,101 individuals. Medication records of participants were used to identify individuals prescribed medications with a genetic variant that might alter efficacy.Results:A total of 395 sequence variants, including 19 PharmGKB 1A and 1B variants, were identified in SNP chip sequence data, and 388 variants, including 21 PharmGKB 1A and 1B variants, were identified in the exome sequence data. Nine participants had incidental pharmacogenetic variants associated with altered efficacy of a prescribed medication.Conclusions:Despite the small size of the NIH UDP patient cohort, we identified pharmacogenetic incidental findings potentially useful for guiding therapy. Consequently, groups conducting clinical genomic studies might consider reporting of pharmacogenetic incidental findings.",
keywords = "NIH undiagnosed diseases program, next generation sequencing, pharmacogenomics, precision medicine, secondary findings",
author = "Lee, {Elizabeth M.J.} and Karen Xu and Emma Mosbrook and Amanda Links and Jessica Guzman and Adams, {David R.} and Elise Flynn and Elise Valkanas and Camillo Toro and Tifft, {Cynthia J.} and Boerkoel, {Cornelius F.} and Gahl, {William A.} and Murat Sincan",
year = "2016",
month = "12",
day = "1",
doi = "10.1038/gim.2016.47",
language = "English (US)",
volume = "18",
pages = "1303--1307",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Pharmacogenomic incidental findings in 308 families

T2 - The NIH Undiagnosed Diseases Program experience

AU - Lee, Elizabeth M.J.

AU - Xu, Karen

AU - Mosbrook, Emma

AU - Links, Amanda

AU - Guzman, Jessica

AU - Adams, David R.

AU - Flynn, Elise

AU - Valkanas, Elise

AU - Toro, Camillo

AU - Tifft, Cynthia J.

AU - Boerkoel, Cornelius F.

AU - Gahl, William A.

AU - Sincan, Murat

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Purpose:Using single-nucleotide polymorphism (SNP) chip and exome sequence data from individuals participating in the National Institutes of Health (NIH) Undiagnosed Diseases Program (UDP), we evaluated the number and therapeutic informativeness of incidental pharmacogenetic variants.Methods:Pharmacogenomics Knowledgebase (PharmGKB) annotated sequence variants were identified in 1,101 individuals. Medication records of participants were used to identify individuals prescribed medications with a genetic variant that might alter efficacy.Results:A total of 395 sequence variants, including 19 PharmGKB 1A and 1B variants, were identified in SNP chip sequence data, and 388 variants, including 21 PharmGKB 1A and 1B variants, were identified in the exome sequence data. Nine participants had incidental pharmacogenetic variants associated with altered efficacy of a prescribed medication.Conclusions:Despite the small size of the NIH UDP patient cohort, we identified pharmacogenetic incidental findings potentially useful for guiding therapy. Consequently, groups conducting clinical genomic studies might consider reporting of pharmacogenetic incidental findings.

AB - Purpose:Using single-nucleotide polymorphism (SNP) chip and exome sequence data from individuals participating in the National Institutes of Health (NIH) Undiagnosed Diseases Program (UDP), we evaluated the number and therapeutic informativeness of incidental pharmacogenetic variants.Methods:Pharmacogenomics Knowledgebase (PharmGKB) annotated sequence variants were identified in 1,101 individuals. Medication records of participants were used to identify individuals prescribed medications with a genetic variant that might alter efficacy.Results:A total of 395 sequence variants, including 19 PharmGKB 1A and 1B variants, were identified in SNP chip sequence data, and 388 variants, including 21 PharmGKB 1A and 1B variants, were identified in the exome sequence data. Nine participants had incidental pharmacogenetic variants associated with altered efficacy of a prescribed medication.Conclusions:Despite the small size of the NIH UDP patient cohort, we identified pharmacogenetic incidental findings potentially useful for guiding therapy. Consequently, groups conducting clinical genomic studies might consider reporting of pharmacogenetic incidental findings.

KW - NIH undiagnosed diseases program

KW - next generation sequencing

KW - pharmacogenomics

KW - precision medicine

KW - secondary findings

UR - http://www.scopus.com/inward/record.url?scp=85000631020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000631020&partnerID=8YFLogxK

U2 - 10.1038/gim.2016.47

DO - 10.1038/gim.2016.47

M3 - Article

C2 - 27253732

AN - SCOPUS:85000631020

VL - 18

SP - 1303

EP - 1307

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 12

ER -